Publications - IR Sant Pau

Search

21/07/2023 SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe

Pennells, L, Kaptoge, S, Ostergaard, HB, Read, SH, Carinci, F, Franch-Nadal, J, Petitjean, C, Taylor, O, Hageman, SHJ, Xu, Z, Shi, FC, Spackman, S, Gualdi, S, Holman, N, Costa, RBDE, Bonnet, F, Brenner, H, Kiechl, S, Lawlor, DA, Potier, L, Schottker, B, Sofat, R, Volzke, H, Willeit, J, Baltane, Z, Fava, S, Janos, S, Lavens, A, Pildava, S, Poljicanin, T, Pristas, I, Rossing, P, Sascha, R, Scheidt-Nave, C, Stotl, I, Tibor, G, Urbancic-Rovan, V, Vanherwegen, AS, Vistisen, D, Du, Y, Walker, MR, Willeit, P, Ference, B, De Bacquer, D, Halle, M, Huculeci, R, McEvoy, JW, Timmis, A, Vardas, P, Dorresteijn, JAN, Graham, I, Wood, A, Eliasson, B, Herrington, W, Danesh, J, Mauricio, D, Benedetti, MM, Sattar, N, Visseren, FLJ, Wild, S, Di Angelantonio, E, Balkau, B, Fumeron, F, Stocker, H, Holleczek, B, Schipf, S, Schmidt, CO, Doerr, M, Tilg, H, Leitner, C, Notdurfter, M, Taylor, J, Dale, C, Prieto-Merino, D, Gillum, RF, Buble, T, Ivanko, P, Carstensen, B, Heidemann, C, Gall, T, Sandor, J, Lepiksone, J, Magri, CJ, Azzopardi, J, Real, J, Vlacho, B, Mata-Cases, M. SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe. EUROPEAN HEART JOURNAL. 2023; 44(28)DOI:10.1093/eurheartj/ehad260. PMID:37247330. IF:38.100(Q1/1D).

14/07/2023 Epidemiology of the first-ever cardiovascular event in people with type 1 diabetes: a retrospective cohort population-based study in Catalonia

Giménez-Pérez G., Vinals, C, Mata-Cases M., Vlacho B., Real J., Franch-Nadal J., Ortega E., Mauricio D.. Epidemiology of the first-ever cardiovascular event in people with type 1 diabetes: a retrospective cohort population-based study in Catalonia. Cardiovascular Diabetology. 2023; 22(1)DOI:10.1186/s12933-023-01917-1. PMID:37452416. IF:8.500(Q1/1D).

01/07/2023 NAD plus Precursors and Intestinal Inflammation: Therapeutic Insights Involving Gut Microbiota

Nino-Narvion, J, Rojo-Lopez, MI, Martinez-Santos, P, Rossell, J, Ruiz-Alcaraz, AJ, Alonso, N, Ramos-Molina, B, Mauricio, D, Julve, J. NAD plus Precursors and Intestinal Inflammation: Therapeutic Insights Involving Gut Microbiota. Nutrients. 2023; 15(13)DOI:10.3390/nu15132992. PMID:37447318. IF:4.800(Q1/2D).

01/07/2023 Connected Insulin Pens and Caps: An Expert's Recommendation from the Area of Diabetes of the Spanish Endocrinology and Nutrition Society (SEEN)

Tejera-Perez, C, Chico, A, Azriel-Mira, S, Lardies-Sanchez, B, Gomez-Peralta, F. Connected Insulin Pens and Caps: An Expert's Recommendation from the Area of Diabetes of the Spanish Endocrinology and Nutrition Society (SEEN). Diabetes Therapy. 2023; 14(7)DOI:10.1007/s13300-023-01417-1. PMID:37188930. IF:2.800(Q3/6D).

02/06/2023 NOD mouse dorsal root ganglia display morphological and gene expression defects before and during autoimmune diabetes development

Corral-Pujol M., Arpa B., Rosell-Mases E., Egia-Mendikute L., Mora C., Stratmann T., Sanchez A., Casanovas A., Esquerda J.E., Mauricio D., Vives-Pi M., Verdaguer J.. NOD mouse dorsal root ganglia display morphological and gene expression defects before and during autoimmune diabetes development. Frontiers in Endocrinology. 2023; 14DOI:10.3389/fendo.2023.1176566. PMID:37334284. IF:3.900(Q2/3D).

01/06/2023 Cumulative tobacco consumption has a dose-dependent effect on atheromatosis burden and improves severe atheromatosis prediction in asymptomatic middle-aged individuals: The ILERVAS study

Bermudez-Lopez, M, Marti-Antonio, M, Castro-Boque, E, Bretones, MD, Farras, C, Gonzalez, J, Pamplona, R, Lecube, A, Mauricio, D, Cambray, S, Valdivielso, JM, Fernandez, E. Cumulative tobacco consumption has a dose-dependent effect on atheromatosis burden and improves severe atheromatosis prediction in asymptomatic middle-aged individuals: The ILERVAS study. ATHEROSCLEROSIS. 2023; 375DOI:10.1016/j.atherosclerosis.2023.05.002. PMID:37276714. IF:4.900(Q1/2D).

01/06/2023 The Bittersweet Beat: Diabetes Complications

Rossell, J, Rojo-Lopez, MI, Julve, J, Mauricio, D. The Bittersweet Beat: Diabetes Complications. Journal of Clinical Medicine. 2023; 12(12)DOI:10.3390/jcm12124018. PMID:37373711. IF:3.000(Q1/2D).

17/05/2023 Hybrid closed-loop systems can help patients with extreme fear of hypoglycemia or hyperglycemia

Mangas, N, Mateu-Salat, M, Martinez, MJ, Lopez, A, Pujol, I, Martinez, C, Corcoy, R. Hybrid closed-loop systems can help patients with extreme fear of hypoglycemia or hyperglycemia. Hormones-International Journal of Endocrinology and Metabolism. 2023; 22(3)DOI:10.1007/s42000-023-00451-9. PMID:37198528. IF:2.400(Q3/7D).

11/05/2023 Contribution of Elevated Glucose and Oxidized LDL to Macrophage Inflammation: A Role for PRAS40/Akt-Dependent Shedding of Soluble CD14

Sanjurjo, L, Castelblanco, E, Julve, J, Villalmanzo, N, Tellez, E, Ramirez-Morros, A, Alonso, N, Mauricio, D, Sarrias, MR. Contribution of Elevated Glucose and Oxidized LDL to Macrophage Inflammation: A Role for PRAS40/Akt-Dependent Shedding of Soluble CD14. Antioxidants. 2023; 12(5)DOI:10.3390/antiox12051083. PMID:37237950. IF:6.000(Q1/2D).

08/05/2023 Lower risk of cardiovascular events and death associated with initiation of sodium-glucose cotransporter-2 inhibitors versus sulphonylureas: Analysis from the CVD-REAL 2 study

Goh, SY, Kosiborod, MN, Lam, CSP, Cavender, MA, Kohsaka, S, Norhammar, A, Birkeland, KI, Holl, RW, Mauricio, D, Tangri, N, Shaw, JE, Thuresson, M, Fenici, P, Kim, DJ. Lower risk of cardiovascular events and death associated with initiation of sodium-glucose cotransporter-2 inhibitors versus sulphonylureas: Analysis from the CVD-REAL 2 study. DIABETES OBESITY & METABOLISM. 2023; 25(8)DOI:10.1111/dom.15092. PMID:37055714. IF:5.400(Q1/2D).

01/05/2023 Gestational weight gain and pregnancy outcomes in women with type 1 and type 2 diabetes mellitus

Xie X., Liu J., García-Patterson A., Chico A., Mateu-Salat M., Amigó J., Adelantado J.M., Corcoy R.. Gestational weight gain and pregnancy outcomes in women with type 1 and type 2 diabetes mellitus. ACTA DIABETOLOGICA. 2023; 60(5)DOI:10.1007/s00592-023-02031-0. PMID:36707439. IF:3.100(Q2/5D).

01/05/2023 Research Priorities for Precision Medicine in NAFLD

Iruzubieta, P, Bataller, R, Arias-Loste, MT, Arrese, M, Calleja, JL, Castro-Narro, G, Cusi, K, Dillon, JF, Martinez-Chantar, ML, Mateo, M, Perez, A, Rinella, ME, Romero-Gomez, M, Schattenberg, JM, Zelber-Sagi, S, Crespo, J, Lazarus, JV. Research Priorities for Precision Medicine in NAFLD. Clinics in Liver Disease. 2023; 27(2)DOI:10.1016/j.cld.2023.01.016. PMID:37024222. IF:2.900(Q2/5D).

17/04/2023 FTY720-P, a Biased S1PR Ligand, Increases Mitochondrial Function through STAT3 Activation in Cardiac Cells

Munoz, JP, Sanchez-Fernandez-de-Landa, P, Diarte-Anazco, EMG, Zorzano, A, Blanco-Vaca, F, Julve, J. FTY720-P, a Biased S1PR Ligand, Increases Mitochondrial Function through STAT3 Activation in Cardiac Cells. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023; 24(8)DOI:10.3390/ijms24087374. PMID:37108539. IF:4.900(Q1/3D).

06/04/2023 Consensus-based recommendations on physical activity and exercise in patients with diabetes at risk of foot ulcerations: a Delphi study

Gracia-Sanchez, A, Lopez-Pineda, A, Lazaro-Martinez, JL, Perez, A, Pomares-Gomez, FJ, Fernandez-Seguin, LM, Gil-Guillen, VF, Chicharro-Luna, E. Consensus-based recommendations on physical activity and exercise in patients with diabetes at risk of foot ulcerations: a Delphi study. Brazilian Journal of Physical Therapy. 2023; 27(2)DOI:10.1016/j.bjpt.2023.100500. PMID:37079949. IF:3.100(Q1/1D).

01/04/2023 Impact of a multicomponent healthcare intervention on glycaemic control in subjects with poorly controlled type 2 diabetes: The INTEGRA study

Mollo, A, Vlacho, B, Gratacos, M, Mata-Cases, M, Rubinat, E, Berenguera, A, Real, J, Puig-Treserra, R, Cos, X, Franch-Nadal, J, Khunti, K, Mauricio, D, INTEGRA Res grp. Impact of a multicomponent healthcare intervention on glycaemic control in subjects with poorly controlled type 2 diabetes: The INTEGRA study. DIABETES OBESITY & METABOLISM. 2023; 25(4)DOI:10.1111/dom.14951. PMID:36546592. IF:5.400(Q1/2D).

01/04/2023 Efficacy, Safety, and Satisfaction with the Accu-Chek Insight with Diabeloop Closed-Loop System in Subjects with Type 1 Diabetes: A Multicenter Real-World Study

Chico, A, de Solis, SN, Lainez, M, Rius, F, Cuesta, M. Efficacy, Safety, and Satisfaction with the Accu-Chek Insight with Diabeloop Closed-Loop System in Subjects with Type 1 Diabetes: A Multicenter Real-World Study. Diabetes Technology & Therapeutics. 2023; 25(4)DOI:10.1089/dia.2022.0449. PMID:36724301. IF:5.700(Q1/2D).

01/04/2023 Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should be included in a basic lipid profile?

Velilla, TA, Guijarro, C, Ruiz, RC, Pinero, MR, Marcos, JFV, Perez, AP, Lopez, MAB, Lopez, AM, Donaire, JAG, Obaya, JC, Guerra, LC, Carratala, VP, Cabello, IE, Lazo, MS, Rodrigo, MMC, Prieto, JMM, Doblas, JJG, Soto, AB. Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should be included in a basic lipid profile?. Clinica E Investigacion En Arteriosclerosis. 2023; 35(2)DOI:10.1016/j.arteri.2022.10.002. PMID:36925360. IF:(Q/D).

24/03/2023 Adherence to the therapeutic guidelines recommendations among the people with type 2 diabetes mellitus and obesity, frailty, or recent diagnosis, attended in primary health care centers in Spain: A cross-sectional study

Vlacho B., Mata-Cases M., Fernandez-Camins B., Liebana, LR, Barrot-de la Puente J., Franch-Nadal J.. Adherence to the therapeutic guidelines recommendations among the people with type 2 diabetes mellitus and obesity, frailty, or recent diagnosis, attended in primary health care centers in Spain: A cross-sectional study. Frontiers in Medicine. 2023; 10DOI:10.3389/fmed.2023.1138956. PMID:37035300. IF:3.100(Q1/2D).

01/03/2023 Essential protein P116 extracts cholesterol and other indispensable lipids for Mycoplasmas

Sprankel L., Vizarraga D., Martín J., Manger S., Meier-Credo J., Marcos M., Julve J., Rotllan N., Scheffer M.P., Escolà-Gil J.C., Langer J.D., Piñol J., Fita I., Frangakis A.S.. Essential protein P116 extracts cholesterol and other indispensable lipids for Mycoplasmas. NATURE STRUCTURAL & MOLECULAR BIOLOGY. 2023; 30(3)DOI:10.1038/s41594-023-00922-y. PMID:36782049. IF:12.500(Q1/1D).

01/03/2023 Caffeine and the Risk of Diabetic Retinopathy in Type 2 Diabetes Mellitus: Findings from Clinical and Experimental Studies

Alcubierre, N, Granado-Casas, M, Bogdanov, P, Hernandez, C, Ramos, H, Castelblanco, E, Real, J, Rubinat-Arnaldo, E, Traveset, A, Hernandez, M, Jurjo, C, Vioque, J, Navarrete-Munoz, EM, Simo, R, Mauricio, D. Caffeine and the Risk of Diabetic Retinopathy in Type 2 Diabetes Mellitus: Findings from Clinical and Experimental Studies. Nutrients. 2023; 15(5)DOI:10.3390/nu15051169. PMID:36904168. IF:4.800(Q1/2D).

01/03/2023 Fatty Acid Binding Proteins 3 and 4 Predict Both All-Cause and Cardiovascular Mortality in Subjects with Chronic Heart Failure and Type 2 Diabetes Mellitus

Rodriguez-Calvo, R, Granado-Casas, M, de Oca, APM, Julian, MT, Domingo, M, Codina, P, Santiago-Vacas, E, Cediel, G, Julve, J, Rossell, J, Masana, L, Mauricio, D, Lupon, J, Bayes-Genis, A, Alonso, N. Fatty Acid Binding Proteins 3 and 4 Predict Both All-Cause and Cardiovascular Mortality in Subjects with Chronic Heart Failure and Type 2 Diabetes Mellitus. Antioxidants. 2023; 12(3)DOI:10.3390/antiox12030645. PMID:36978893. IF:6.000(Q1/2D).

01/03/2023 Circulating Small Noncoding RNA Profiling as a Potential Biomarker of Atherosclerotic Plaque Composition in Type 1 Diabetes

Giannella, A, Castelblanco, E, Zambon, CF, Basso, D, Hernandez, M, Ortega, E, Alonso, N, Mauricio, D, Avogaro, A, Ceolotto, G, Vigili de Kreutzenberg, S. Circulating Small Noncoding RNA Profiling as a Potential Biomarker of Atherosclerotic Plaque Composition in Type 1 Diabetes. DIABETES CARE. 2023; 46(3)DOI:10.2337/dc22-1441. PMID:36577032. IF:14.800(Q1/1D).

01/03/2023 Circulating metabolomic and lipidomic changes in subjects with new-onset type 1 diabetes after optimization of glycemic control

Julve, J, Genua, I, Quifer-Rada, P, Yanes, O, Barranco-Altirriba, M, Hernandez, M, Junza, A, Capellades, J, Granado-Casas, M, Alonso, N, Castelblanco, E, Mauricio, D. Circulating metabolomic and lipidomic changes in subjects with new-onset type 1 diabetes after optimization of glycemic control. DIABETES RESEARCH AND CLINICAL PRACTICE. 2023; 197DOI:10.1016/j.diabres.2023.110578. PMID:36804334. IF:6.100(Q1/2D).

28/02/2023 Prediction of outcomes in subjects with type 2 diabetes and diabetic foot ulcers in Catalonian primary care centers: a multicenter observational study

Bundo, M, Vlacho, B, Llussa, J, Bobe, I, Aivar, M, Ciria, C, Martinez-Sanchez, A, Real, J, Mata-Cases, M, Cos, X, Doria, M, Viade, J, Franch-Nadal, J, Mauricio, D. Prediction of outcomes in subjects with type 2 diabetes and diabetic foot ulcers in Catalonian primary care centers: a multicenter observational study. Journal of Foot and Ankle Research. 2023; 16(1)DOI:10.1186/s13047-023-00602-6. PMID:36849888. IF:2.500(Q1/3D).

01/02/2023 Outcome of COVID-19 infection in people with diabetes mellitus or obesity in the primary care setting in Catalonia, Spain: A retrospective cohort study of the initial three waves

Mauricio, D, Vlacho, B, Ortega, E, Cos-Claramunt, X, Mata-Cases, M, Real, J, Fernandez-Camins, B, Franch-Nadal, J. Outcome of COVID-19 infection in people with diabetes mellitus or obesity in the primary care setting in Catalonia, Spain: A retrospective cohort study of the initial three waves. Primary Care Diabetes. 2023; 17(1)DOI:10.1016/j.pcd.2022.12.002. PMID:36528549. IF:2.600(Q1/3D).

01/01/2023 All-cause and cardiorenal mortality in 6 million adults with and without type 2 diabetes: A comparative, trend analysis in Canada, Spain, and the UK

Ling S., Zaccardi F., Vlacho B., Li P., Gatius, JR, Mata-Cases M., Franch-Nadal J., Kosiborod M.N., Gillies C., Fenici P., Mauricio D., Shah B.R., Khunti K.. All-cause and cardiorenal mortality in 6 million adults with and without type 2 diabetes: A comparative, trend analysis in Canada, Spain, and the UK. DIABETES OBESITY & METABOLISM. 2023; 25(1)DOI:10.1111/dom.14856. PMID:36056765. IF:5.400(Q1/2D).

01/01/2023 Type 2 Diabetes mellitus alters the cargo of (poly)phenol metabolome and the oxidative status in circulating lipoproteins

Reis A., Rocha S., Dias I.H., Costa R., Soares R., Sánchez-Quesada J.L., Perez A., de Freitas V.. Type 2 Diabetes mellitus alters the cargo of (poly)phenol metabolome and the oxidative status in circulating lipoproteins. Redox Biology. 2023; 59DOI:10.1016/j.redox.2022.102572. PMID:36516720. IF:10.700(Q1/1D).

01/01/2023 Glycaemic Control in People with Type 2 Diabetes Mellitus Switching from Basal Insulin to Insulin Glargine 300 U/ml (Gla-300): Results from the REALI Pooled Database

Muller-Wieland, D, Freemantle, N, Bonadonna, RC, Mauquoi, C, Bigot, G, Bonnemaire, M, Gourdy, P, Mauricio, D. Glycaemic Control in People with Type 2 Diabetes Mellitus Switching from Basal Insulin to Insulin Glargine 300 U/ml (Gla-300): Results from the REALI Pooled Database. Diabetes Therapy. 2023; 14(2)DOI:10.1007/s13300-022-01356-3. PMID:36596946. IF:2.800(Q3/6D).

01/01/2023 Is There a Link between Obesity Indices and Skin Autofluorescence? A Response from the ILERVAS Project

Sánchez E., Sánchez M., López-Cano C., Bermúdez-López M., Valdivielso J.M., Farras-Salles, C, Pamplona R., Torres G., Mauricio D., Castro E., Fernández E., Lecube A.. Is There a Link between Obesity Indices and Skin Autofluorescence? A Response from the ILERVAS Project. Nutrients. 2023; 15(1)DOI:10.3390/nu15010203. PMID:36615860. IF:4.800(Q1/2D).

01/01/2023 Obesity and fertility. Position statement

Miñambres I., de Hollanda A., Vilarrasa N., Pellitero S., Rubio M.A., Flores L., Caixàs A., Lobo S., Martinez Salamanca J.I., Acevedo B., Moizé V., Andreu A., Escalada J.. Obesity and fertility. Position statement. Endocrinologia Diabetes y Nutricion. 2023; 70DOI:10.1016/j.endinu.2022.10.002. PMID:. IF:(Q/D).

01/01/2023 Treatment of hypertriglyceridaemia with icosapent ethyl in patients with high/very high cardiovascular risk. Consensus document of the Sociedad Española de Cardiología

Pedro-Botet J., Barrios V., Sánchez-Margalet V., Tamargo J., Arrieta F., Gámez J.M., Gimeno-Orna J.A., Escobar C., Gómez-Doblas J.J., Pérez A.. Treatment of hypertriglyceridaemia with icosapent ethyl in patients with high/very high cardiovascular risk. Consensus document of the Sociedad Española de Cardiología. Endocrinologia Diabetes y Nutricion. 2023; 70DOI:10.1016/j.endinu.2022.03.004. PMID:. IF:(Q/D).

01/01/2023 Insulin degludec versus insulin detemir, both in combination with insulin aspart, in the treatment of pregnant women with type 1 diabetes (EXPECT): an open-label, multinational, randomised, controlled, non-inferiority trial

Mathiesen E.R., Alibegovic A.C., Corcoy R., Dunne F., Feig D.S., Hod M., Jia T., Kalyanam B., Kar S., Kautzky-Willer A., Marchesini C., Rea R.D., Damm P.. Insulin degludec versus insulin detemir, both in combination with insulin aspart, in the treatment of pregnant women with type 1 diabetes (EXPECT): an open-label, multinational, randomised, controlled, non-inferiority trial. Lancet Diabetes & Endocrinology. 2023; 11(2)DOI:10.1016/S2213-8587(22)00307-2. PMID:36623517. IF:44.000(Q1/1D).

01/01/2023 Abdominal obesity and dsyglycemia are risk factors for liver fibrosis progression in NAFLD subjects: A population-based study

Julián M.T., Ballesta S., Pera G., Pérez-Montes de Oca A., Soldevila B., Caballería L., Morillas R., Expósito C., Martínez–Escudé A., Puig-Domingo M., Franch-Nadal J., Torán P., Cusi K., Julve J., Mauricio D., Alonso N.. Abdominal obesity and dsyglycemia are risk factors for liver fibrosis progression in NAFLD subjects: A population-based study. Frontiers in Endocrinology. 2023; 13DOI:10.3389/fendo.2022.1051958. PMID:36714592. IF:3.900(Q2/3D).

01/01/2023 Continuous glucose monitoring and metrics for clinical trials: an international consensus statement

Battelino T., Alexander C.M., Amiel S.A., Arreaza-Rubin G., Beck R.W., Bergenstal R.M., Buckingham B.A., Carroll J., Ceriello A., Chow E., Choudhary P., Close K., Danne T., Dutta S., Gabbay R., Garg S., Heverly J., Hirsch I.B., Kader T., Kenney J., Kovatchev B., Laffel L., Maahs D., Mathieu C., Mauricio D., Nimri R., Nishimura R., Scharf M., Del Prato S., Renard E., Rosenstock J., Saboo B., Ueki K., Umpierrez G.E., Weinzimer S.A., Phillip M.. Continuous glucose monitoring and metrics for clinical trials: an international consensus statement. Lancet Diabetes & Endocrinology. 2023; 11(1)DOI:10.1016/S2213-8587(22)00319-9. PMID:36493795. IF:44.000(Q1/1D).

01/01/2023 Spanish Consensus on the Use of isCGM in the Management of Patients With Insulin Therapy: The MONITOR Project

Ampudia-Blasco F.J., Ugarte-Abasolo E., Chico A., García-Alemán J., Galan-Barroso M.. Spanish Consensus on the Use of isCGM in the Management of Patients With Insulin Therapy: The MONITOR Project. Journal Of Diabetes Science And Technology. 2023; 17(5)DOI:10.1177/19322968221087270. PMID:35466722. IF:(Q/D).

01/01/2023 Low adherence to the Mediterranean diet is associated with increased prevalence and number of atherosclerotic plaques in the ILERVAS cohort

Rojo-López M.I., Bermúdez-López M., Castro E., Farràs C., Torres G., Pamplona R., Lecube A., Valdivielso J.M., Fernández E., Julve J., Castelblanco E., Franch-Nadal J., Alonso N., Granado-Casas M., Mauricio D., Miquel E., Ortega M., Barbé F., González J., Barril S., Sánchez-de-la-Torre M., Portero-Otín M., Jové M., Hernández M., Rius F., Godoy P., Alonso M.M.. Low adherence to the Mediterranean diet is associated with increased prevalence and number of atherosclerotic plaques in the ILERVAS cohort. ATHEROSCLEROSIS. 2023; 380DOI:10.1016/j.atherosclerosis.2023.117191. PMID:37586219. IF:4.900(Q1/2D).

01/01/2023 Rapid Reduction of HbA1c and Early Worsening of Diabetic Retinopathy: A Real-world Population-Based Study in Subjects With Type 2 Diabetes

Simo R., Franch-Nadal J., Vlacho B., Real J., Amado E., Flores J., Mata-Cases M., Ortega E., Rigla M., Valles J.-A., Hernandez C., Mauricio D.. Rapid Reduction of HbA1c and Early Worsening of Diabetic Retinopathy: A Real-world Population-Based Study in Subjects With Type 2 Diabetes. DIABETES CARE. 2023; 46(9)DOI:10.2337/dc22-2521. PMID:37428631. IF:14.800(Q1/1D).

01/01/2023 Physical activity and sedentary time across pregnancy and associations with neonatal weight, adiposity and cord blood parameters: a secondary analysis of the DALI study

Dieberger A.M., Obermayer-Pietsch B., Harreiter J., Desoye G., van Poppel M.N.M., Simmons D., Corcoy R., Perez J.M.A., Kautzky-Willer A., Damm P., Mathiesen E., Jensen D.M., Andersen L.L.T., Dunne F., Lapolla A., Dalfra M.G., Bertolotto A., Jelsma J.G.M., Galjaard S., Wender-Ozegowska E., Zawiejska A., Hill D., Devlieger R., Snoek F.J.. Physical activity and sedentary time across pregnancy and associations with neonatal weight, adiposity and cord blood parameters: a secondary analysis of the DALI study. INTERNATIONAL JOURNAL OF OBESITY. 2023; 47(9)DOI:10.1038/s41366-023-01347-9. PMID:37500924. IF:4.200(Q1/3D).

01/01/2023 Dietary ?3 Fatty Acids and Phytosterols in the Modulation of the HDL Lipidome: A Longitudinal Crossover Clinical Study

Padro T., López-Yerena A., Pérez A., Vilahur G., Badimon L.. Dietary ?3 Fatty Acids and Phytosterols in the Modulation of the HDL Lipidome: A Longitudinal Crossover Clinical Study. Nutrients. 2023; 15(16)DOI:10.3390/nu15163637. PMID:37630826. IF:4.800(Q1/2D).

01/01/2023 Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should be included in a basic lipid profile?

Arrobas Velilla T., Guijarro C., Campuzano Ruiz R., Rodríguez Piñero M., Valderrama Marcos J.F., Pérez Pérez A., Botana López M.A., Morais López A., García Donaire J.A., Obaya J.C., Castilla Guerra L., Pallares Carratalá V., Egocheaga Cabello I., Salgueira Lazo M., Castellanos Rodrigo M.M., Mostaza Prieto J.M., Gómez Doblas J.J., Buño Soto A.. Consensus document for lipid profile determination and reporting in Spanish clinical laboratories. What parameters should be included in a basic lipid profile?. REVISTA CLINICA ESPANOLA. 2023; 223(7)DOI:10.1016/j.rce.2022.11.001. PMID:37302464. IF:2.300(Q2/3D).

01/12/2022 Adherence to antidiabetic treatment among patients managed in primary care centres in Spain: the INTENSE study

Vlacho, B, Simarro, FL, Mata-Cases, M, Miravet, S, Escribano-Serrano, J, Asensio, D, Cortes, X, Franch-Nadal, J. Adherence to antidiabetic treatment among patients managed in primary care centres in Spain: the INTENSE study. Primary Care Diabetes. 2022; 16(6)DOI:10.1016/j.pcd.2022.10.004. PMID:36335018. IF:2.900(Q2/5D).

24/11/2022 The novel inflammatory biomarker GlycA and triglyceride-rich lipoproteins are associated with the presence of subclinical myocardial dysfunction in subjects with type 1 diabetes mellitus

Puig-Jove, C, Julve, J, Castelblanco, E, Julian, MT, Amigo, N, Andersen, HU, Ahluwalia, TS, Rossing, P, Mauricio, D, Jensen, MT, Alonso, N. The novel inflammatory biomarker GlycA and triglyceride-rich lipoproteins are associated with the presence of subclinical myocardial dysfunction in subjects with type 1 diabetes mellitus. Cardiovascular Diabetology. 2022; 21(1)DOI:10.1186/s12933-022-01652-z. PMID:36434633. IF:9.300(Q1/1D).

24/11/2022 Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk

Das Pradhan, A, Glynn, RJ, Fruchart, JC, MacFadyen, JG, Zaharris, ES, Everett, BM, Campbell, SE, Oshima, R, Amarenco, P, Blom, DJ, Brinton, EA, Eckel, RH, Elam, MB, Felicio, JS, Ginsberg, HN, Goudev, A, Ishibashi, S, Joseph, J, Kodama, T, Koenig, W, Leiter, LA, Lorenzatti, AJ, Mankovsky, B, Marx, N, Nordestgaard, BG, Pall, D, Ray, KK, Santos, RD, Soran, H, Susekov, A, Tendera, M, Yokote, K, Paynter, NP, Buring, JE, Libby, P, Ridker, PM, PEREZ PEREZ, ANTONIO, Prominent Investigators. Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk. NEW ENGLAND JOURNAL OF MEDICINE. 2022; 387(21)DOI:10.1056/NEJMoa2210645. PMID:36342113. IF:158.500(Q1/1D).

03/11/2022 Diabetic retinopathy predicts cardiovascular disease independently of subclinical atherosclerosis in individuals with type 2 diabetes: A prospective cohort study

Castelblanco, E, Granado-Casas, M, Hernandez, M, Pinyol, M, Correig, E, Julve, J, Rojo-Lopez, MI, Alonso, N, Avogaro, A, Ortega, E, Mauricio, D. Diabetic retinopathy predicts cardiovascular disease independently of subclinical atherosclerosis in individuals with type 2 diabetes: A prospective cohort study. Frontiers in Cardiovascular Medicine. 2022; 9DOI:10.3389/fcvm.2022.945421. PMID:36407461. IF:3.600(Q2/5D).

01/11/2022 Longitudinal deep learning clustering of Type 2 Diabetes Mellitus trajectories using routinely collected health records

Manzini, E, Vlacho, B, Franch-Nadal, J, Escudero, J, Genova, A, Reixach, E, Andres, E, Pizarro, I, Portero, JL, Mauricio, D, Perera-Lluna, A. Longitudinal deep learning clustering of Type 2 Diabetes Mellitus trajectories using routinely collected health records. JOURNAL OF BIOMEDICAL INFORMATICS. 2022; 135DOI:10.1016/j.jbi.2022.104218. PMID:36216232. IF:4.500(Q2/4D).

01/11/2022 Divergent Effects of Glycemic Control and Bariatric Surgery on Circulating Concentrations of TMAO in Newly Diagnosed T2D Patients and Morbidly Obese

Canyelles, M, Perez, A, Junza, A, Minambres, I, Yanes, O, Sarda, H, Rotllan, N, Julve, J, Sanchez-Quesada, JL, Tondo, M, Escola-Gil, JC, Blanco-Vaca, F. Divergent Effects of Glycemic Control and Bariatric Surgery on Circulating Concentrations of TMAO in Newly Diagnosed T2D Patients and Morbidly Obese. Diagnostics. 2022; 12(11)DOI:10.3390/diagnostics12112783. PMID:36428843. IF:3.600(Q2/4D).

01/11/2022 Executive summary of the consensus statement of: Clinical recommendations for sport practice in people with diabetes (RECORD Guide). Update 2021. Diabetes Mellitus Area of the Spanish Society of Endocrinology and Nutrition (SEEN)

Gargallo-Fernandez, M, Escalada-San Martin, J, Chico-Ballesteros, A, Lecumberri-Pascual, E, Tejera-Perez, C, Fernandez-Garcia, JC, Rozas-Moreno, P, Marco-Martinez, A, Gomez-Peralta, F, Lopez-Fernandez, J. Executive summary of the consensus statement of: Clinical recommendations for sport practice in people with diabetes (RECORD Guide). Update 2021. Diabetes Mellitus Area of the Spanish Society of Endocrinology and Nutrition (SEEN). Endocrinologia Diabetes y Nutricion. 2022; 69(9)DOI:10.1016/j.endinu.2021.06.005. PMID:34489216. IF:1.900(Q4/9D).

24/10/2022 Prevalence and risk factors of diabetic foot disease among the people with type 2 diabetes using real-world practice data from Catalonia during 2018

Bundo, M, Vlacho, B, Llussa, J, Puig-Treserra, R, Mata-Cases, M, Cos, X, Jude, EB, Franch-Nadal, J, Mauricio, D. Prevalence and risk factors of diabetic foot disease among the people with type 2 diabetes using real-world practice data from Catalonia during 2018. Frontiers in Endocrinology. 2022; 13DOI:10.3389/fendo.2022.1024904. PMID:36353236. IF:5.200(Q1/3D).

15/10/2022 GlycA and GlycB as Inflammatory Markers in Chronic Heart Failure

Cediel, G, Teis, A, Codina, P, Julve, J, Domingo, M, Santiago-Vacas, E, Castelblanco, E, Amigo, N, Lupon, J, Mauricio, D, Alonso, N, Bayes-Genis, A. GlycA and GlycB as Inflammatory Markers in Chronic Heart Failure. AMERICAN JOURNAL OF CARDIOLOGY. 2022; 181DOI:10.1016/j.amjcard.2022.07.019. PMID:36008162. IF:2.800(Q3/6D).

01/10/2022 Epigenetic Regulation by microRNAs in Hyperhomocysteinemia-Accelerated Atherosclerosis

Grinan, R, Escola-Gil, JC, Julve, J, Benitez, S, Rotllan, N. Epigenetic Regulation by microRNAs in Hyperhomocysteinemia-Accelerated Atherosclerosis. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022; 23(20)DOI:10.3390/ijms232012452. PMID:36293305. IF:5.600(Q1/3D).

01/10/2022 Executive summary on the treatment of type 2 diabetes mellitus in elderly or frail individuals. 2022 update of the 2018 consensus document "Treatment of type 2 diabetes mellitus in the elderly"

Gomez-Peralta, F, Carrasco-Sanchez, FJ, Perez, A, Escalada, J, Alvarez-Guisasola, F, Miranda-Fernandez-Santos, C, Mediavilla-Bravo, JJ, Gomez-Huelgas, R. Executive summary on the treatment of type 2 diabetes mellitus in elderly or frail individuals. 2022 update of the 2018 consensus document "Treatment of type 2 diabetes mellitus in the elderly". REVISTA CLINICA ESPANOLA. 2022; 222(8)DOI:10.1016/j.rce.2022.03.004. PMID:35753941. IF:2.900(Q2/5D).

01/09/2022 Comorbid autoimmune diseases and burden of diabetes-related complications in patients with type 1 diabetes from a Mediterranean area

Gimenez-Perez, G, Vlacho, B, Navas, E, Mata-Cases, M, Real, J, Cos, X, Franch-Nadal, J, Mauricio, D. Comorbid autoimmune diseases and burden of diabetes-related complications in patients with type 1 diabetes from a Mediterranean area. DIABETES RESEARCH AND CLINICAL PRACTICE. 2022; 191DOI:10.1016/j.diabres.2022.110031. PMID:35934173. IF:5.100(Q2/3D).

01/09/2022 Vitamin D3 Supplementation in Overweight/Obese Pregnant Women: No Effects on the Maternal or Fetal Lipid Profile and Body Fat Distribution-A Secondary Analysis of the Multicentric, Randomized, Controlled Vitamin D and Lifestyle for Gestational Diabetes Prevention Trial (DALI)

Harreiter, J, Mendoza, LC, Simmons, D, Desoye, G, Devlieger, R, Galjaard, S, Damm, P, Mathiesen, ER, Jensen, DM, Andersen, LLT, Dunne, F, Lapolla, A, Dalfra, MG, Bertolotto, A, Wender-Ozegowska, E, Zawiejska, A, Hill, D, Jelsma, JGM, Snoek, FJ, Worda, C, Bancher-Todesca, D, van Poppel, MNM, Corcoy, R, Kautzky-Willer, A. Vitamin D3 Supplementation in Overweight/Obese Pregnant Women: No Effects on the Maternal or Fetal Lipid Profile and Body Fat Distribution-A Secondary Analysis of the Multicentric, Randomized, Controlled Vitamin D and Lifestyle for Gestational Diabetes Prevention Trial (DALI). Nutrients. 2022; 14(18)DOI:10.3390/nu14183781. PMID:36145157. IF:5.900(Q1/2D).

14/07/2022 Development and Validation of a Personalized, Sex-Specific Prediction Algorithm of Severe Atheromatosis in Middle-Aged Asymptomatic Individuals: The ILERVAS Study

Bermudez-Lopez, M, Marti-Antonio, M, Castro-Boque, E, Bretones, MD, Farras, C, Torres, G, Pamplona, R, Lecube, A, Mauricio, D, Valdivielso, JM, Fernandez, E. Development and Validation of a Personalized, Sex-Specific Prediction Algorithm of Severe Atheromatosis in Middle-Aged Asymptomatic Individuals: The ILERVAS Study. Frontiers in Cardiovascular Medicine. 2022; 9DOI:10.3389/fcvm.2022.895917. PMID:35928938. IF:3.600(Q2/5D).

01/05/2022 Impaired awareness of hypoglycaemia in women with type 1 diabetes in pregnancy: Hypoglycaemia fear, glycaemic and pregnancy outcomes

Bahrami, J, Tomlinson, G, Murphy, HR, Feig, DS, Corcoy R., CHICO BALLESTEROS, ANA ISABEL, CONCEPTT Collaborative Grp. Impaired awareness of hypoglycaemia in women with type 1 diabetes in pregnancy: Hypoglycaemia fear, glycaemic and pregnancy outcomes. DIABETIC MEDICINE. 2022; 39(5)DOI:10.1111/dme.14789. PMID:35030277. IF:3.500(Q3/6D).

01/05/2022 Physical Activity and Sedentary Time in Pregnancy: An Exploratory Study on Oxidative Stress Markers in the Placenta of Women with Obesity

Zafaranieh, S, Dieberger, AM, Leopold-Posch, B, Huppertz, B, Granitzer, S, Hengstschlager, M, Gundacker, C, Desoye, G, van Poppel, MNM, Corcoy R., DALI Core Investigator Grp. Physical Activity and Sedentary Time in Pregnancy: An Exploratory Study on Oxidative Stress Markers in the Placenta of Women with Obesity. Biomedicines. 2022; 10(5)DOI:10.3390/biomedicines10051069. PMID:35625806. IF:4.700(Q1/3D).

01/02/2022 Reappearance of C-Peptide During the Third Trimester in Type 1 Diabetes Pregnancy: Pancreatic Regeneration or Fetal Hyperinsulinism? Diabetes Care 2021;44:1826-1834

Meek, CL, Oram, RA, McDonald, TJ, Feig, DS, Hattersley, AT, Murphy, HR, Corcoy R., CHICO BALLESTEROS, ANA ISABEL, CONCEPTT Collaborative Grp. Reappearance of C-Peptide During the Third Trimester in Type 1 Diabetes Pregnancy: Pancreatic Regeneration or Fetal Hyperinsulinism? Diabetes Care 2021;44:1826-1834. DIABETES CARE. 2022; 45(2)DOI:10.2337/dci21-0054. PMID:35050370. IF:16.200(Q1/1D).

01/01/2022 Determinants of response to the glucagon-like peptide-1 receptor agonists in a type 2 diabetes population in the real-world

Franch-Nadal J., Granado-Casas M., Mata-Cases M., Ortega E., Vlacho B., Mauricio D.. Determinants of response to the glucagon-like peptide-1 receptor agonists in a type 2 diabetes population in the real-world. Primary Care Diabetes. 2022; 16(6)DOI:10.1016/j.pcd.2022.10.005. PMID:36336605. IF:2.900(Q2/5D).

01/01/2022 Obesity and related comorbidities in a large population-based cohort of subjects with type 1 diabetes in Catalonia

Genua I., Franch-Nadal J., Navas E., Mata-Cases M., Giménez-Pérez G., Vlacho B., Mauricio D., Goday A.. Obesity and related comorbidities in a large population-based cohort of subjects with type 1 diabetes in Catalonia. Frontiers in Endocrinology. 2022; 13DOI:10.3389/fendo.2022.1015614. PMID:36531459. IF:5.200(Q1/3D).

01/01/2022 Dysglycemia in young women attenuates the protective effect against fatty liver disease

Pérez-Montes de Oca A., Julián M.T., Pera G., Caballería L., Morillas R., Torán P., Expósito C., Franch-Nadal J., Mauricio D., Alonso N.. Dysglycemia in young women attenuates the protective effect against fatty liver disease. Frontiers in Endocrinology. 2022; 13DOI:10.3389/fendo.2022.971864. PMID:36479218. IF:5.200(Q1/3D).